Pylera Approval History
- FDA approved: Yes (First approved September 28th, 2006)
- Brand name: Pylera
- Generic name: bismuth subcitrate potassium, metronidazole and tetracycline
- Dosage form: Capsules
- Previous name: Helizide
- Company: Allergan, Inc.
- Treatment for: Helicobacter Pylori Infection
Pylera (bismuth subcitrate potassium, metronidazole and tetracycline) is a 3-in-1 capsule triple therapy indicated for the eradication of Helicobacter pylori, a bacterium now recognized as being the main cause of gastric and duodenal ulcers.
Development History and FDA Approval Process for Pylera
|Sep 28, 2006||Pylera Axcan Pharma Inc. - Treatment for Eradication of Helicobacter pylori|
|Mar 29, 2006||Axcan submits FDA amendment to its new drug application for Helizide|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.